330
Participants
Start Date
June 7, 2023
Primary Completion Date
April 30, 2028
Study Completion Date
December 31, 2028
R-miniCHOP + Acalabrutinib
"* Rituximab i.v.: 375 mg/m2 (D0)~* Cyclophosphamide i.v.: 400 mg/m² (D1)~* Doxorubicin i.v.: 25 mg/m² (D1)~* Vincristine i.v.: 1 mg (D1)~* Prednisolone p.o.: 40 mg/m² (D1 to D5)~* Acalabrutinib 100 mg p.o. twice daily starting from D1 of first R-miniCHOP cycle continuously to D21 of cycle 8.~Cycles repeated every 3 weeks"
R-miniCHOP
"* Rituximab i.v.: 375 mg/m2 (D0)~* Cyclophosphamide i.v.: 400 mg/m² (D1)~* Doxorubicin i.v.: 25 mg/m² (D1)~* Vincristine i.v.: 1 mg (D1)~* Prednisolone p.o.: 40 mg/m² (D1 to D5).~Cycles repeated every 3 weeks"
RECRUITING
Saarland University Medical Center, Homburg
NOT_YET_RECRUITING
MVZ am Klinikum Aschaffenburg, Aschaffenburg
RECRUITING
Helios Klinikum Emil von Behring, Berlin
NOT_YET_RECRUITING
Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin
NOT_YET_RECRUITING
Gemeinschaftspraxis Mohm/Prange-Krex, Dresden
RECRUITING
Universitätsklinikum Gießen und Marburg, Standort Gießen, Giessen
RECRUITING
Universitätsmedizin Greifswald, Greifswald
RECRUITING
Universitätsmedizin Halle (Saale), Halle
RECRUITING
Städtisches Klinikum Karlsruhe, Karlsruhe
NOT_YET_RECRUITING
Johannes Wesling Klinikum, Minden
NOT_YET_RECRUITING
Rheinland Klinikum-Lukaskrankenhaus Neuss, Neuss
NOT_YET_RECRUITING
Brüderkrankenhaus St. Josef, Paderborn
RECRUITING
CaritasKlinikum Saarbrücken St. Theresia, Saarbrücken
RECRUITING
Klinikum Mutterhaus der Borromäerinnen, Trier
NOT_YET_RECRUITING
Krankenhaus der Barmherzigen Brüder Trier, Trier
NOT_YET_RECRUITING
Bundeswehrkrankenhaus Ulm, Ulm
RECRUITING
Universitätsklinikum Ulm, Ulm
Collaborators (1)
University of Leipzig
OTHER
University Hospital Regensburg
OTHER
Wuerzburg University Hospital
OTHER
University Hospital of Gießen and Marburg
UNKNOWN
Saarland University Medical Center
UNKNOWN
AstraZeneca
INDUSTRY
Universität des Saarlandes
OTHER